Inventor
YANG MICHAEL G
US43 patents
⚠️ This page may combine multiple inventors who share the name “YANG MICHAEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
27 patentsUS7163937B2Jan 16, 2007
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO29 citations92
US7001901B2Feb 21, 2006
Tetrazolylpropionamides as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB CO23 citations92
US11021462B2Jun 1, 2021
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO6 citations84
US7378409B2May 27, 2008
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO20 citations83
US11787779B2Oct 17, 2023
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO2 citations73
US10294256B2May 21, 2019
Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO5 citations73
US10166249B2Jan 1, 2019
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO2 citations73
US7629351B2Dec 8, 2009
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process
BRISTOL MYERS SQUIBB CO5 citations73
US7482335B2Jan 27, 2009
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO6 citations73
US10435369B2Oct 8, 2019
Tricyclic sulfones as ROR gamma modulators
BRISTOL MYERS SQUIBB CO6 citations71
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US7671062B2Mar 2, 2010
Modulators of chemokine receptor activity, crystalline forms and process
BRISTOL MYERS SQUIBB CO4 citations63
US12365667B2Jul 22, 2025
Sulfone pyridine alkyl amide-substituted heteroaryl compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11701373B2Jul 18, 2023
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations62
US11058696B2Jul 13, 2021
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations62
US9522888B2Dec 20, 2016
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO2 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US11597721B2Mar 7, 2023
Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO1 citations59
US10781215B2Sep 22, 2020
Heterobicyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
BRISTOL MYERS SQUIBB CO0 citations52
US10709719B2Jul 14, 2020
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations52
US10633339B2Apr 28, 2020
Tricyclic sulfone compound as a ROR gamma modulator
BRISTOL MYERS SQUIBB CO0 citations52
US9770459B2Sep 26, 2017
Substituted bicyclic compounds
BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US12473290B2Nov 18, 2025
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
BRISTOL MYERS SQUIBB CO0 citations51
US9796720B2Oct 24, 2017
Imidazole-derived modulators of the glucocorticoid receptor
BRISTOL MYERS SQUIBB CO0 citations41
US9593113B2Mar 14, 2017
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
BRISTOL MYERS SQUIBB CO0 citations41
BRISTOL MYERS SQUIBB PHARMA CO
10 patentsUS7183282B2Feb 27, 2007
Substituted heterocycle fused γ-carbolines
BRISTOL MYERS SQUIBB PHARMA CO145 citations98
US7655647B2Feb 2, 2010
Substituted lactams as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
US7528249B2May 5, 2009
Cyclic malonamides as inhibitors of aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
US7498324B2Mar 3, 2009
Substituted lactams as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO18 citations93
US7390802B2Jun 24, 2008
Substituted lactams as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO17 citations93
US7390896B2Jun 24, 2008
Cyclic malonamides as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO17 citations93
US7276496B2Oct 2, 2007
Cyclic malonamides as inhibitors of Aβ protein protection
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
US7276495B2Oct 2, 2007
Substituted lactams as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
US7053081B2May 30, 2006
Cyclic malonamides as inhibitors of A-β protein production
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
US6900199B2May 31, 2005
Substituted lactams as inhibitors of Aβ protein production
BRISTOL MYERS SQUIBB PHARMA CO13 citations93
ARIAD PHARMA INC
3 patentsUS6573295B2Jun 3, 2003
Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
ARIAD PHARMA INC17 citations92
US6482852B2Nov 19, 2002
Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
ARIAD PHARMA INC20 citations92
US6576766B1Jun 10, 2003
Signal transduction inhibitors, compositions containing them
ARIAD PHARMA INC12 citations69